Astria Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $706 | $0 | $0 | $0 |
Gross Profit | 706 | |||
EBITDA | -31,643 | -35,820 | -36,995 | -29,591 |
EBIT | -35,820 | -36,995 | -29,547 | |
Net Income | -31,643 | -33,052 | -33,709 | -25,626 |
Net Change In Cash | 706 | 0 | 0 | 0 |
Free Cash Flow | -32,295 | -36,648 | -34,018 | -17,362 |
Cash | 96,280 | 76,319 | 54,385 | 59,820 |
Basic Shares | 58,005 | 58,005 | 58,005 | 56,434 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -111,558 | -83,030 | -51,834 | -30,359 |
EBIT | -111,558 | -67,831 | -53,503 | -30,359 |
Net Income | -94,260 | -72,891 | -50,165 | -194,912 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -65,941 | |||
Free Cash Flow | -81,537 | -68,470 | -43,624 | -30,172 |
Cash | 59,820 | 175,530 | 20,525 | 86,508 |
Basic Shares | 56,161 | 30,123 | 14,620 | 8,925 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.55 |
2025-06-30 | -$0.57 |
2025-03-31 | -$0.58 |
2024-12-31 | -$0.44 |
